Hester Biosciences Limited
NSE: HESTERBIO.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Rajiv Dinesh Gandhi
- Employees
- 642
- Headquarters
- Ahmedabad, India
- IPO year
- 2015
- Market cap
- ₹14.0B
- Website
- https://www.hester.in
Loading HESTERBIO…
Loading profile data…Frequently asked questions about HESTERBIO
What does Hester Biosciences Limited (HESTERBIO.NS) do?
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg dr...
Where does HESTERBIO.NS trade?
Hester Biosciences Limited (HESTERBIO.NS) trades on the National Stock Exchange of India.
What sector is HESTERBIO.NS in?
Hester Biosciences Limited (HESTERBIO.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hester Biosciences Limited?
Rajiv Dinesh Gandhi is the chief executive officer of Hester Biosciences Limited (HESTERBIO.NS).
Where is Hester Biosciences Limited headquartered?
Hester Biosciences Limited is headquartered in India.
Does HESTERBIO.NS pay a dividend?
Yes — Hester Biosciences Limited (HESTERBIO.NS) paid a trailing twelve-month dividend of INR 7.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did HESTERBIO.NS go public?
Hester Biosciences Limited (HESTERBIO.NS) completed its initial public offering in 2015.